<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Brief antecedent periods of coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> improve subsequent vessel patency in damaged and stenotic coronary arteries via release of <z:chebi fb="3" ids="16335">adenosine</z:chebi> from ischemic/reperfused myocardium and resultant <z:chebi fb="3" ids="16335">adenosine</z:chebi> receptor stimulation </plain></SENT>
<SENT sid="1" pm="."><plain>However, the site of receptor stimulation-circulating blood-borne elements (ie, platelets) versus vessel-wall components of the culprit artery-remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>If platelet <z:chebi fb="3" ids="16335">adenosine</z:chebi> receptors are involved, then the benefits of brief <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> (1) should be manifested systemically and improve patency at a remote site and (2) should be inhibited by an <z:chebi fb="68" ids="48706">antagonist</z:chebi> of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A(2) receptors, whereas, in contrast, (3) brief <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> not associated with appreciable <z:chebi fb="3" ids="16335">adenosine</z:chebi> release should be ineffective in improving vessel patency </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: In Protocol 1, anesthetized rabbits received 5 minutes of transient <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e>, 5 minutes of transient bilateral carotid occlusion (purported to cause negligible <z:chebi fb="3" ids="16335">adenosine</z:chebi> release from the brain), or no intervention </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> rabbits then underwent injury plus stenosis of the left carotid artery, resulting in repeated cyclic variations in carotid blood flow (CFVs) </plain></SENT>
<SENT sid="5" pm="."><plain>Carotid patency during the initial 2 hours after stenosis (assessed by quantifying the nadir of the CFVs and area of the flow-time profile) was significantly enhanced with antecedent coronary-but not carotid-occlusion versus controls </plain></SENT>
<SENT sid="6" pm="."><plain>In Protocol 2, improvement in carotid patency after brief <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> was corroborated in anesthetized dogs </plain></SENT>
<SENT sid="7" pm="."><plain>However, the benefits of brief <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> were abrogated by the A(2)/A(1) <z:chebi fb="68" ids="48706">antagonist</z:chebi> CGS 15943 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Brief antecedent coronary <z:mp ids='MP_0006134'>artery occlusion</z:mp> enhanced vessel patency in remote, damaged, and stenotic carotid arteries, largely due to <z:chebi fb="3" ids="16335">adenosine</z:chebi> receptor stimulation on circulating elements </plain></SENT>
</text></document>